← Leaderboards
Seth Braunstein
University Of Pennsylvania
$400,186
Attributed
$400,186
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$400,186 · 1
By mechanism
M01$400,186 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Linda H Aiken$18,471,178
- Ian Frank$25,757,892
- Rob R Macgregor$4,980,820
- Peter J. Snyder$40,848,094
- Harvey Michael Friedman$28,257,678
Others in their field
Top investigators on “Aminoguanidine”
- Timothy S Kern · Case Western Reserve University$8,028,418
- Eric A Newman · University Of Minnesota Twin Cities$3,325,297
- Raja G Khalifah · Praetego, Inc.$2,439,824
- Cindy Ann Burklow · Naprogenix, Inc$2,398,306
- Diane E Heck · Rutgers The St Univ Of Nj New Brunswick$2,225,814
- Jeffry Stephen Nyman · Veterans Health Administration$2,220,473
Research focus
AminoguanidineClinical ResearchDiabetes Mellitus TherapyDiabetic NephropathyDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationKidney Disorder ChemotherapyKidney FunctionNoninsulin Dependent Diabetes MellitusOutcomes Research
Grant awards (3)
AMINOGUANIDINE IN PATIENTS WITH TYPE II DIABETES AND OVERT DIABETIC NEPHROPATHY$187,536
M01 · FY2000 · RR
AMINOGUANIDINE IN PATIENTS WITH TYPE II DIABETES AND OVERT DIABETIC NEPHROPATHY$187,536
M01 · FY2000 · RR
AMINOGUANIDINE IN PATIENTS WITH TYPE II DIABETES AND OVERT DIABETIC NEPHROPATHY$25,114
M01 · FY2000 · RR